Genetic testing for cancer predisposition--an ongoing debate

Same author

Hereditary conditions in which the loss of heterozygosity may be important.

Mutation research·1992

Same author

Infectious bursal disease of poultry: antigenic structure of the virus and control.

Veterinary microbiology·1992

Same author

Sub-acute effects of interferon-alpha 2 on adrenocorticotrophic hormone, cortisol, growth hormone and prolactin in humans.

Psychoneuroendocrinology·1992

Same author

Recurrence of hepatitis C virus infection after orthotopic liver transplantation.

Transplantation·1992

Same author

[HIV detection in the bone transplant with polymerase chain reaction].

Der Unfallchirurg·1992

Same author

Relation between leukocyte counts and cortisol secretion in CML patients undergoing combined TNF alpha/IFN alpha therapy.

Annals of hematology·1992

Same journal

Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial.

The Lancet. Oncology·2026

Same journal

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

The Lancet. Oncology·2026

Same journal

Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation Oncology.

The Lancet. Oncology·2026

Same journal

European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine.

The Lancet. Oncology·2026

Same journal

Novel strategies to overcome the blood-brain barrier in triple-negative breast cancer brain metastases.

The Lancet. Oncology·2026

Same journal

Correction to Lancet Oncol 2025; 26: e369-80.

The Lancet. Oncology·2026

Related Experiment Videos

Genetic testing for cancer predisposition--an ongoing debate

Related Concept Videos

Hereditary conditions in which the loss of heterozygosity may be important.

Infectious bursal disease of poultry: antigenic structure of the virus and control.

Sub-acute effects of interferon-alpha 2 on adrenocorticotrophic hormone, cortisol, growth hormone and prolactin in humans.

Recurrence of hepatitis C virus infection after orthotopic liver transplantation.

[HIV detection in the bone transplant with polymerase chain reaction].

Relation between leukocyte counts and cortisol secretion in CML patients undergoing combined TNF alpha/IFN alpha therapy.

Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial.

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation Oncology.

European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine.

Novel strategies to overcome the blood-brain barrier in triple-negative breast cancer brain metastases.

Correction to Lancet Oncol 2025; 26: e369-80.

Related Experiment Videos

Genetic testing for cancer predisposition--an ongoing debate

Related Concept Videos

Related Articles

Hereditary conditions in which the loss of heterozygosity may be important.

Infectious bursal disease of poultry: antigenic structure of the virus and control.

Sub-acute effects of interferon-alpha 2 on adrenocorticotrophic hormone, cortisol, growth hormone and prolactin in humans.

Recurrence of hepatitis C virus infection after orthotopic liver transplantation.

[HIV detection in the bone transplant with polymerase chain reaction].

Relation between leukocyte counts and cortisol secretion in CML patients undergoing combined TNF alpha/IFN alpha therapy.

Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial.

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation Oncology.

European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine.

Novel strategies to overcome the blood-brain barrier in triple-negative breast cancer brain metastases.

Correction to Lancet Oncol 2025; 26: e369-80.